Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Noelin1 Affects Lateral Mobility of Synaptic AMPA Receptors.

Pandya NJ, Seeger C, Babai N, Gonzalez-Lozano MA, Mack V, Lodder JC, Gouwenberg Y, Mansvelder HD, Danielson UH, Li KW, Heine M, Spijker S, Frischknecht R, Smit AB.

Cell Rep. 2018 Jul 31;24(5):1218-1230. doi: 10.1016/j.celrep.2018.06.102.

2.

Control of viral transcripts as a concept for future HBV therapies.

Seeger C.

Curr Opin Virol. 2018 Jun;30:18-23. doi: 10.1016/j.coviro.2018.01.009. Epub 2018 Feb 20. Review.

PMID:
29453098
3.

Tuwongella immobilis gen. nov., sp. nov., a novel non-motile bacterium within the phylum Planctomycetes.

Seeger C, Butler MK, Yee B, Mahajan M, Fuerst JA, Andersson SGE.

Int J Syst Evol Microbiol. 2017 Dec;67(12):4923-4929. doi: 10.1099/ijsem.0.002271. Epub 2017 Oct 31.

4.

Distribution of Hepatitis B Virus Nuclear DNA.

Li M, Sohn JA, Seeger C.

J Virol. 2017 Dec 14;92(1). pii: e01391-17. doi: 10.1128/JVI.01391-17. Print 2018 Jan 1.

5.

A research agenda for curing chronic hepatitis B virus infection.

Alter H, Block T, Brown N, Brownstein A, Brosgart C, Chang KM, Chen PJ, Chisari FV, Cohen C, El-Serag H, Feld J, Gish R, Glenn J, Greten T, Guo H, Guo JT, Hoshida Y, Hu J, Kowdley KV, Li W, Liang J, Locarnini S, Lok AS, Mason W, McMahon B, Mehta A, Perrillo R, Revill P, Rice CM, Rinaudo J, Schinazi R, Seeger C, Shetty K, Tavis J, Zoulim F.

Hepatology. 2018 Mar;67(3):1127-1131. doi: 10.1002/hep.29509. Epub 2018 Jan 24. No abstract available.

6.

Biophysical analysis of the dynamics of calmodulin interactions with neurogranin and Ca2+ /calmodulin-dependent kinase II.

Seeger C, Talibov VO, Danielson UH.

J Mol Recognit. 2017 Aug;30(8). doi: 10.1002/jmr.2621. Epub 2017 Apr 27.

7.

Visual Analytics for Mobile Eye Tracking.

Kurzhals K, Hlawatsch M, Seeger C, Weiskopf D.

IEEE Trans Vis Comput Graph. 2017 Jan;23(1):301-310.

PMID:
27875146
8.

Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA.

Seeger C, Sohn JA.

Mol Ther. 2016 Aug;24(7):1258-66. doi: 10.1038/mt.2016.94. Epub 2016 May 16.

9.

HBV replication, pathobiology and therapy: Unanswered questions.

Seeger C, Mason WS.

J Hepatol. 2016 Apr;64(1 Suppl):S1-S3. doi: 10.1016/j.jhep.2016.01.006.

PMID:
27084030
10.

Analysis of the leakage of gene repression by an artificial TetR-regulated promoter in cyanobacteria.

Huang HH, Seeger C, Danielson UH, Lindblad P.

BMC Res Notes. 2015 Sep 19;8:459. doi: 10.1186/s13104-015-1425-0.

11.

Hepadnavirus Genome Replication and Persistence.

Hu J, Seeger C.

Cold Spring Harb Perspect Med. 2015 Jul 1;5(7):a021386. doi: 10.1101/cshperspect.a021386. Review.

12.

Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair?

Cui X, McAllister R, Boregowda R, Sohn JA, Cortes Ledesma F, Caldecott KW, Seeger C, Hu J.

PLoS One. 2015 Jun 16;10(6):e0128401. doi: 10.1371/journal.pone.0128401. eCollection 2015.

13.

Molecular biology of hepatitis B virus infection.

Seeger C, Mason WS.

Virology. 2015 May;479-480:672-86. doi: 10.1016/j.virol.2015.02.031. Epub 2015 Mar 7. Review.

14.

Targeting Hepatitis B Virus With CRISPR/Cas9.

Seeger C, Sohn JA.

Mol Ther Nucleic Acids. 2014 Dec 16;3:e216. doi: 10.1038/mtna.2014.68.

15.

Rethinking the core list of journals for libraries that serve schools and colleges of pharmacy.

Beckett RD, Cole SW, Rogers HK, Bickett S, Seeger C, McDaniel JA.

J Med Libr Assoc. 2014 Oct;102(4):292-6. doi: 10.3163/1536-5050.102.4.011.

16.

Virology. Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA".

Chisari FV, Mason WS, Seeger C.

Science. 2014 Jun 13;344(6189):1237. doi: 10.1126/science.1254082.

17.

MyHealthAssistant: an event-driven middleware for multiple medical applications on a smartphone-mediated body sensor network.

Seeger C, Van Laerhoven K, Buchmann A.

IEEE J Biomed Health Inform. 2015 Mar;19(2):752-60. doi: 10.1109/JBHI.2014.2326604. Epub 2014 May 22.

PMID:
24876136
18.

Sodium-dependent taurocholic cotransporting polypeptide: a candidate receptor for human hepatitis B virus.

Seeger C, Mason WS.

Gut. 2013 Aug;62(8):1093-5. doi: 10.1136/gutjnl-2013-304594. Epub 2013 Mar 29. Review. No abstract available.

PMID:
23542357
19.

Kinetic and mechanistic differences in the interactions between caldendrin and calmodulin with AKAP79 suggest different roles in synaptic function.

Seeger C, Gorny X, Reddy PP, Seidenbecher C, Danielson UH.

J Mol Recognit. 2012 Oct;25(10):495-503. doi: 10.1002/jmr.2215.

PMID:
22996592
20.

The Healthy Start project: a randomized, controlled intervention to prevent overweight among normal weight, preschool children at high risk of future overweight.

Olsen NJ, Buch-Andersen T, Händel MN, Ostergaard LM, Pedersen J, Seeger C, Stougaard M, Trærup M, Livemore K, Mortensen EL, Holst C, Heitmann BL.

BMC Public Health. 2012 Aug 1;12:590. doi: 10.1186/1471-2458-12-590.

21.

AKAP79/150 interacts with the neuronal calcium-binding protein caldendrin.

Gorny X, Mikhaylova M, Seeger C, Reddy PP, Reissner C, Schott BH, Helena Danielson U, Kreutz MR, Seidenbecher C.

J Neurochem. 2012 Aug;122(4):714-26. doi: 10.1111/j.1471-4159.2012.07828.x. Epub 2012 Jul 10.

22.

Histaminergic pharmacology of homo-oligomeric β3 γ-aminobutyric acid type A receptors characterized by surface plasmon resonance biosensor technology.

Seeger C, Christopeit T, Fuchs K, Grote K, Sieghart W, Danielson UH.

Biochem Pharmacol. 2012 Aug 1;84(3):341-51. doi: 10.1016/j.bcp.2012.04.008. Epub 2012 Apr 15. Erratum in: Biochem Pharmacol. 2012 Dec 1;84(11):1541.

PMID:
22531219
23.

[Immune reactions to posterior lamellar versus penetrating keratoplasty. A retrospective analysis].

Bertelmann E, Seeger C, Rieck P, Torun N.

Ophthalmologe. 2012 Mar;109(3):257-62. doi: 10.1007/s00347-011-2486-7. German.

PMID:
22354579
24.

West Nile virus infection induces depletion of IFNAR1 protein levels.

Evans JD, Crown RA, Sohn JA, Seeger C.

Viral Immunol. 2011 Aug;24(4):253-63. doi: 10.1089/vim.2010.0126.

25.

Identification of a novel scaffold for allosteric inhibition of wild type and drug resistant HIV-1 reverse transcriptase by fragment library screening.

Geitmann M, Elinder M, Seeger C, Brandt P, de Esch IJ, Danielson UH.

J Med Chem. 2011 Feb 10;54(3):699-708. doi: 10.1021/jm1010513. Epub 2011 Jan 5.

PMID:
21207961
26.

Distribution of health-related physical fitness in Texas youth: a demographic and geographic analysis.

Welk GJ, Meredith MD, Ihmels M, Seeger C.

Res Q Exerc Sport. 2010 Sep;81(3 Suppl):S6-15.

PMID:
21049833
27.

Mechanism for CCC DNA synthesis in hepadnaviruses.

Sohn JA, Litwin S, Seeger C.

PLoS One. 2009 Nov 30;4(11):e8093. doi: 10.1371/journal.pone.0008093.

28.

Focal distribution of hepatitis C virus RNA in infected livers.

Stiffler JD, Nguyen M, Sohn JA, Liu C, Kaplan D, Seeger C.

PLoS One. 2009 Aug 18;4(8):e6661. doi: 10.1371/journal.pone.0006661.

29.
30.

Cardif: a protein central to innate immunity is inactivated by the HCV NS3 serine protease.

Evans JD, Seeger C.

Hepatology. 2006 Mar;43(3):615-7. No abstract available.

PMID:
16496328
31.

Salient molecular features of hepatitis C virus revealed.

Seeger C.

Trends Microbiol. 2005 Nov;13(11):528-34. Epub 2005 Sep 8. Review.

PMID:
16154356
32.

The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon.

Hayashi J, Stoyanova R, Seeger C.

Virology. 2005 May 10;335(2):264-75.

33.

West Nile virus inhibits the signal transduction pathway of alpha interferon.

Guo JT, Hayashi J, Seeger C.

J Virol. 2005 Feb;79(3):1343-50.

34.

Genome-wide analyses of avian sarcoma virus integration sites.

Narezkina A, Taganov KD, Litwin S, Stoyanova R, Hayashi J, Seeger C, Skalka AM, Katz RA.

J Virol. 2004 Nov;78(21):11656-63.

35.

Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus.

Zhu Y, Cullen JM, Aldrich CE, Saputelli J, Miller D, Seeger C, Mason WS, Jilbert AR.

Virology. 2004 Sep 15;327(1):26-40.

36.

Mechanism of the interferon alpha response against hepatitis C virus replicons.

Guo JT, Sohn JA, Zhu Q, Seeger C.

Virology. 2004 Jul 20;325(1):71-81.

37.
38.
39.

Conditional replication of duck hepatitis B virus in hepatoma cells.

Guo JT, Pryce M, Wang X, Barrasa MI, Hu J, Seeger C.

J Virol. 2003 Feb;77(3):1885-93.

40.

Effect of alpha interferon on the hepatitis C virus replicon.

Guo JT, Bichko VV, Seeger C.

J Virol. 2001 Sep;75(18):8516-23.

41.
42.

Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.

Zhou T, Guo JT, Nunes FA, Molnar-Kimber KL, Wilson JM, Aldrich CE, Saputelli J, Litwin S, Condreay LD, Seeger C, Mason WS.

J Virol. 2000 Dec;74(24):11754-63.

43.

Hepatitis B virus biology.

Seeger C, Mason WS.

Microbiol Mol Biol Rev. 2000 Mar;64(1):51-68. Review.

44.

Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections.

Guo JT, Zhou H, Liu C, Aldrich C, Saputelli J, Whitaker T, Barrasa MI, Mason WS, Seeger C.

J Virol. 2000 Feb;74(3):1495-505.

45.

Why are hepadnaviruses DNA and not RNA viruses?

Seeger C, Hu J.

Trends Microbiol. 1997 Nov;5(11):447-50. Review.

PMID:
9402701
46.

PNA-mediated purification of PCR amplifiable human genomic DNA from whole blood.

Seeger C, Batz HG, Orum H.

Biotechniques. 1997 Sep;23(3):512-7.

47.

Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication.

Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH, Guo JT, Seeger C, King RW.

Antimicrob Agents Chemother. 1997 Aug;41(8):1715-20.

48.
50.

Superradiant laser with partial atomic cooperativity.

Seeger C, Kolobov MI, Kus M, Haake F.

Phys Rev A. 1996 Nov;54(5):4440-4452. No abstract available.

PMID:
9913995

Supplemental Content

Loading ...
Support Center